India to United States: Busulfan Export Trade Route
India has recorded 9 verified shipments of Busulfan exported to United States, representing a combined trade value of $366.7K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $40.7K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 99% of total export value with 6 shipments worth $364.1K USD. On the buying side, MYLAN INSTITUTIONAL INC GSO is the largest importer in United States with $156.5K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Busulfan corridor is one of India's established pharmaceutical export routes, with 9 shipments documented worth a combined $366.7K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 99% of all export value, reflecting the consolidated nature of India's busulfan manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $40.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with busulfan's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 20.8%, placing it at rank #8 among India's top busulfan export destinations globally.
On the import side, key buyers of Indian busulfan in United States include MYLAN INSTITUTIONAL INC GSO, EVERSANA LIFE SCIENCES SERVICES,LL, EVERSANA LIFE SCIENCES SERVICESLLC and 4 others. MYLAN INSTITUTIONAL INC GSO is the single largest importer with 2 shipments valued at $156.5K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#8
- Annual growth+20.8%
- Demand growth+19.5%
- Regulatory ease74/100
Top 10 Indian Busulfan Exporters to United States
Showing top 10 of 3 Indian suppliers exporting Busulfan to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $60.7K per shipment | 6 | $364.1K | 99.3% |
| 2 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $1.3K per shipment | 2 | $2.6K | 0.7% |
| 3 | EMCURE PHARMACEUTICALS LIMITED Avg $0 per shipment | 1 | $0 | 0.0% |
This table shows the top 10 of 3 Indian companies exporting busulfan to United States, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED. INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 6 shipments worth $364.1K USD, giving it a 99% market share.
Top 10 Busulfan Importers in United States
Showing top 10 of 7 known buyers in United States receiving Busulfan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian busulfan in United States include MYLAN INSTITUTIONAL INC GSO, EVERSANA LIFE SCIENCES SERVICES,LL, EVERSANA LIFE SCIENCES SERVICESLLC, TO THE ORDER, VERONICA HERNANDEZ HDZ, among 7 total buyers. The largest importer is MYLAN INSTITUTIONAL INC GSO, accounting for $156.5K USD across 2 shipments — representing 43% of all busulfan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MYLAN INSTITUTIONAL INC GSO | 2 | $156.5K | 42.7% |
| 2 | EVERSANA LIFE SCIENCES SERVICES,LL | 2 | $80.4K | 21.9% |
| 3 | EVERSANA LIFE SCIENCES SERVICESLLC | 1 | $79.7K | 21.7% |
| 4 | TO THE ORDER | 1 | $47.5K | 12.9% |
| 5 | VERONICA HERNANDEZ HDZ | 1 | $2.3K | 0.6% |
| 6 | MCALLEN MAILBOX CENTER VERONICA HERN | 1 | $357 | 0.1% |
| 7 | Nexus Pharmaceuticals Inc | 1 | $0 | 0.0% |
Top 10 Busulfan Formulations Imported by United States
Showing top 10 of 8 product formulations shipped on the India to United States Busulfan route, ranked by trade value
United States imports a wide range of busulfan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BUSULFAN INJ 6MG/ML 10ML 1X8V MYLAN USA — accounts for $156.5K USD across 2 shipments. A total of 8 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BUSULFAN INJ 6MG/ML 10ML 1X8V MYLAN USA | 2 | $156.5K | 42.7% |
| 2 | PHA.DRU & MEDI BUSULFAN INJECTION6MG/ML10ML8V(ACC-US EACH ML CONTAINS BUSULFAN USP 6 MG 1239X1X8VIAL | 1 | $79.7K | 21.7% |
| 3 | PHARMA DRUGS AND MEDI BUSULFAN INJECTION6MG/ML,10ML8V(ACC-US) BUSULFAN USP 6 MG | 1 | $47.5K | 12.9% |
| 4 | PHA.DRU & MEDI, BUSULFAN INJECTION6MG/ML,10ML8V(ACC-US Each mL contains Busulfan USP 6 mg 623X1X8VIAL | 1 | $40.6K | 11.1% |
| 5 | PHA.DRU & MEDI, BUSULFAN INJECTION6MG/ML,10ML8V(ACC-US Each mL contains Busulfan USP 6 mg 611X1X8VIAL | 1 | $39.8K | 10.8% |
| 6 | BUCELON 60 MG ( BUSULFAN ) INJ. | 1 | $2.3K | 0.6% |
| 7 | Bucelon 60 mg Busulfan Inj. | 1 | $357 | 0.1% |
| 8 | BUSULFAN USP | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 4 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's busulfan exports to United States are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $40.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pha.dru & medi busulfan injection6mg/ml10ml8v(acc-us each ml contains busulfan usp 6 mg 1239x1x8vial and pharma drugs and medi busulfan injection6mg/ml,10ml8v(acc-us) busulfan usp 6 mg, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MYLAN INSTITUTIONAL INC GSO is the largest importer with 2 shipments worth $156.5K USD — representing 43% of all busulfan imports from India on this route. A total of 7 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $366.7K
- Avg. Shipment
- $40.7K
- Suppliers
- 3
- Buyers
- 7
- Transit (Sea)
- ~15 days
- Annual Growth
- +20.8%
Reverse Direction
United States → India — Busulfan (Import)Other Busulfan Routes
Unlock the Full India to United States Busulfan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — India to United States Busulfan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Busulfan to United States?
The leading Indian exporters of Busulfan to United States are INTAS PHARMACEUTICALS LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 99% of total trade value on this route.
Q What is the total value of Busulfan exports from India to United States?
India exports Busulfan to United States worth approximately $366.7K USD across 9 recorded shipments. The average value per shipment is $40.7K USD.
Q Which ports does India use to ship Busulfan to United States?
The most active port of origin is SAHAR AIR with 4 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 21% by air.
Q How long does shipping take from India to United States for Busulfan?
The average transit time for Busulfan shipments from India to United States is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Busulfan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 20.8% with demand growth tracking at 19.5%. The route is ranked #8 among India's top Busulfan export destinations globally.
Q How many suppliers are active on the India to United States Busulfan route?
There are currently 3 active Indian suppliers exporting Busulfan to United States. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 99% of total shipment value.
Q Who are the main importers of Busulfan from India in United States?
The leading importers of Indian Busulfan in United States include MYLAN INSTITUTIONAL INC GSO, EVERSANA LIFE SCIENCES SERVICES,LL, EVERSANA LIFE SCIENCES SERVICESLLC, TO THE ORDER, VERONICA HERNANDEZ HDZ. MYLAN INSTITUTIONAL INC GSO is the largest buyer with 2 shipments worth $156.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Busulfan.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 7 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists